News | August 04, 2023
Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023
Norgestrel and Ethinyl Estradiol Tablets USP (RLD Lo/Ovral-28) had an estimated annual sale of USD 34 million in the U.S. (IQVIA MAT Mar 2023)
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
Subscribe To Our Newsletter & Stay Updated
